Akebia Therapeutics

red tape pause delay countdown FDA cancel stop
Biotech

Akebia says FDA staffing issues are delaying appeal process

Akebia says regulators' review of a formal rejection appeal is being delayed due to staffing constraints.
Max Bayer Feb 21, 2023 10:45am
head to head against clash football helmets fight combat

Akebia is taking the fight to the FDA months after rejection

Nov 4, 2022 12:02pm
Missed target failed trial trial failure

Akebia's anemia drug just misses in a COVID-19 trial

Aug 5, 2022 10:14am
Woman tears agreement documents in front of agent

After dispute, Otsuka pays Akebia $55M to exit anemia pill pacts

Jul 1, 2022 8:15am
Parachute

Fierce Biotech launches layoff tracker—Chutes and Ladders

Apr 8, 2022 9:30am
FDA Building 2

Vifor buys priority review voucher for vadadustat filing

Feb 18, 2020 8:12am